These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 26612465

  • 1. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
    Hatori A, Yui J, Xie L, Kumata K, Yamasaki T, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Wang F, Zhang MR.
    Sci Rep; 2015 Nov 27; 5():17327. PubMed ID: 26612465
    [Abstract] [Full Text] [Related]

  • 2. Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).
    Hatori A, Yui J, Xie L, Yamasaki T, Kumata K, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Zhang MR.
    PLoS One; 2014 Nov 27; 9(1):e86625. PubMed ID: 24466178
    [Abstract] [Full Text] [Related]

  • 3. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa).
    Hatori A, Yui J, Yamasaki T, Xie L, Kumata K, Fujinaga M, Yoshida Y, Ogawa M, Nengaki N, Kawamura K, Fukumura T, Zhang MR.
    PLoS One; 2012 Nov 27; 7(9):e45065. PubMed ID: 22984611
    [Abstract] [Full Text] [Related]

  • 4. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.
    Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, Yamasaki T, Nengaki N, Higuchi M, Zhang MR.
    J Nucl Med; 2010 Aug 27; 51(8):1301-9. PubMed ID: 20660373
    [Abstract] [Full Text] [Related]

  • 5. In vivo imaging and quantitative analysis of TSPO in rat peripheral tissues using small-animal PET with [18F]FEDAC.
    Yanamoto K, Kumata K, Fujinaga M, Nengaki N, Takei M, Wakizaka H, Hosoi R, Momosaki S, Yamasaki T, Yui J, Kawamura K, Hatori A, Inoue O, Zhang MR.
    Nucl Med Biol; 2010 Oct 27; 37(7):853-60. PubMed ID: 20870161
    [Abstract] [Full Text] [Related]

  • 6. Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease.
    Xie L, Yui J, Hatori A, Yamasaki T, Kumata K, Wakizaka H, Yoshida Y, Fujinaga M, Kawamura K, Zhang MR.
    J Hepatol; 2012 Nov 27; 57(5):1076-82. PubMed ID: 22796156
    [Abstract] [Full Text] [Related]

  • 7. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, Mantzilas D, Oulie I, Rogstad A, Trigg W, Jones PA.
    Nucl Med Biol; 2015 Sep 27; 42(9):711-9. PubMed ID: 26072270
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.
    Yanamoto K, Yamasaki T, Kumata K, Yui J, Odawara C, Kawamura K, Hatori A, Inoue O, Yamaguchi M, Suzuki K, Zhang MR.
    Synapse; 2009 Nov 27; 63(11):961-71. PubMed ID: 19593823
    [Abstract] [Full Text] [Related]

  • 9. 18F-FEDAC as a Targeting Agent for Activated Macrophages in DBA/1 Mice with Collagen-Induced Arthritis: Comparison with 18F-FDG.
    Chung SJ, Yoon HJ, Youn H, Kim MJ, Lee YS, Jeong JM, Chung JK, Kang KW, Xie L, Zhang MR, Cheon GJ.
    J Nucl Med; 2018 May 27; 59(5):839-845. PubMed ID: 29326355
    [Abstract] [Full Text] [Related]

  • 10. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.
    Lavisse S, Guillermier M, Hérard AS, Petit F, Delahaye M, Van Camp N, Ben Haim L, Lebon V, Remy P, Dollé F, Delzescaux T, Bonvento G, Hantraye P, Escartin C.
    J Neurosci; 2012 Aug 08; 32(32):10809-18. PubMed ID: 22875916
    [Abstract] [Full Text] [Related]

  • 11. Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application.
    Kawamura K, Kumata K, Takei M, Furutsuka K, Hashimoto H, Ito T, Shiomi S, Fujishiro T, Watanabe R, Igarashi N, Muto M, Yamasaki T, Yui J, Xie L, Hatori A, Zhang Y, Nemoto K, Fujibayashi Y, Zhang MR.
    Nucl Med Biol; 2016 Jul 08; 43(7):445-53. PubMed ID: 27183465
    [Abstract] [Full Text] [Related]

  • 12. [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.
    Xie L, Yamasaki T, Ichimaru N, Yui J, Kawamura K, Kumata K, Hatori A, Nonomura N, Zhang MR, Li XK, Takahara S.
    J Neuroimmune Pharmacol; 2012 Mar 08; 7(1):231-42. PubMed ID: 22038158
    [Abstract] [Full Text] [Related]

  • 13. In vivo imaging of activated macrophages by 18F-FEDAC, a TSPO targeting PET ligand, in the use of biologic disease-modifying anti-rheumatic drugs (bDMARDs).
    Chung SJ, Youn H, Jeong EJ, Park CR, Kim MJ, Kang KW, Zhang MR, Cheon GJ.
    Biochem Biophys Res Commun; 2018 Nov 17; 506(1):216-222. PubMed ID: 30343885
    [Abstract] [Full Text] [Related]

  • 14. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images.
    Damont A, Médran-Navarrete V, Cacheux F, Kuhnast B, Pottier G, Bernards N, Marguet F, Puech F, Boisgard R, Dollé F.
    J Med Chem; 2015 Sep 24; 58(18):7449-64. PubMed ID: 26280386
    [Abstract] [Full Text] [Related]

  • 15. [18F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis.
    Shao T, Chen Z, Belov V, Wang X, Rwema SH, Kumar V, Fu H, Deng X, Rong J, Yu Q, Lang L, Lin W, Josephson L, Samir AE, Chen X, Chung RT, Liang SH.
    J Hepatol; 2020 Jul 24; 73(1):161-169. PubMed ID: 32145257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC.
    J Nucl Med; 2012 Feb 24; 53(2):287-94. PubMed ID: 22251555
    [Abstract] [Full Text] [Related]

  • 19. In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid.
    Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J, Trigg W, Michael-Titus AT.
    Eur J Nucl Med Mol Imaging; 2016 Aug 24; 43(9):1710-22. PubMed ID: 27154521
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.